ODTX(Odyssey Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-05-11 | TPG GP A, LLC | Former 10% Owner | 公开市场买入 | 1,388,889 | $18.00 |
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC | 10% 股东 | 公开市场买入 | 200,000 | $18.00 |
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC | 10% 股东 | 公开市场卖出 | 438 | $18.00 |
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC | 10% 股东 | 公开市场买入 | 133,333 | $18.00 |
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC | 10% 股东 | 公开市场卖出 | 277 | $18.00 |
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC | 10% 股东 | 公开市场买入 | 222,222 | $18.00 |
| 2026-05-11 | SR ONE CAPITAL MANAGEMENT, LLC | 10% 股东 | 公开市场卖出 | 1,065 | $18.00 |
| 2026-05-11 | Li Nan (LN) | 董事 | 公开市场买入 | 1,111,111 | $18.00 |
| 2026-05-11 | Chu Shelley | 董事 | 公开市场买入 | 11,111 | $18.00 |
| 2026-05-08 | Dimension Capital II, L.P. | 董事 | 公开市场买入 | 1,111,111 | $18.00 |
| 2026-05-08 | LEIDEN JEFFREY M | 董事 | 公开市场买入 | 5,000 | $20.00 |
| 2026-05-08 | Haas Jason | Chief Financial Officer | 公开市场买入 | 1,000 | $20.00 |